Objective: To estimate the number of regular and dependent methamphetamine users in Australia.
Design: Indirect prevalence estimates were made for each year from 2002–03 to 2013–14. We applied multiplier methods to data on treatment episodes for amphetamines (eg, counselling, rehabilitation, detoxification) and amphetamine-related hospitalisations to estimate the numbers of regular (at least monthly) and dependent methamphetamine users for each year. Dependent users comprised a subgroup of those who used the drug regularly, so that estimates of the sizes of these two populations were not additive.
Results: We estimated that during 2013–14 there were 268 000 regular methamphetamine users (95% CI, 187 000–385 000) and 160 000 dependent users (95% CI, 110 000–232 000) aged 15–54 years in Australia. This equated to population rates of 2.09% (95% CI, 1.45–3.00%) for regular and 1.24% (95% CI, 0.85–1.81%) for dependent use. The rate of dependent use had increased since 2009–10 (when the rate was estimated to be 0.74%), and was higher than the previous peak (1.22% in 2006–07). The highest rates were consistently among those aged 25–34 years, in whom the rate of dependent use during 2012–2013 was estimated to be 1.50% (95% CI, 1.05–2.22%). There had also been an increase in the rate of dependent use among those aged 15–24 years (in 2012–13 reaching 1.14%; 95% CI, 0.80–1.69%).
Conclusions: There have been increases over the past 12 years in the numbers of regular and dependent methamphetamine users in Australia. Our estimates suggest that the most recent numbers are the highest for this period, and that the increase has been most marked among young adults (those aged 15–34 years).
Implications: There is an increasing need for health services to engage with people who have developed problems related to their methamphetamine use.
- 1. Frost C. The ice epidemic is Australia’s very worst history repeating itself. Daily Telegraph (Sydney) 2015; 20 Apr. http://www.dailytelegraph.com.au/rendezview/the-ice-epidemic-is-australias-very-worst-history-repeating-itself/story-fnpug1jf-1227312178593?sv=803268530d2c42eed809bfa035fa7220 (accessed Dec 2015).
- 2. AAP. Prime Minister Tony Abbott says ice is the worst drug problem Australia has ever faced. Sydney Morning Herald 2015; 8 Apr. http://www.smh.com.au/federal-politics/political-news/prime-minister-tony-abbott-says-ice-is-the-worst-drug-problem-australia-has-ever-faced-20150408-1mgi7u.html (accessed Dec 2015).
- 3. Australian Customs and Border Protection Service. Annual report 2013–2014. Canberra: ACBPS, 2014. https://www.border.gov.au/ReportsandPublications/Documents/annual-reports/ACBPS_AR_2013-14.pdf (accessed Dec 2015).
- 4. Lee N. Are we in the midst of an ice epidemic? A snapshot of meth use in Australia. The Conversation [internet] 2015; 8 Apr. http://theconversation.com/are-we-in-the-midst-of-an-ice-epidemic-a-snapshot-of-meth-use-in-australia-39697 (accessed Dec 2015).
- 5. Fitzgerald J. Political fear-mongering just magnifies the harm ice can do. The Conversation [internet] 2015; 13 Apr. http://theconversation.com/political-fear-mongering-just-magnifies-the-harm-ice-can-do-39992 (accessed Dec 2015).
- 6. Australian Institute of Health and Welfare. National Drug Strategy Household Survey 2013 (Drug statistics series no. 28; Cat. no. PHE 183). Canberra: AIHW, 2014. http://www.aihw.gov.au/alcohol-and-other-drugs/ndshs-2013/ (accessed Dec 2015).
- 7. Hickman M, Taylor C, Chatterjee A, et al. Estimating the prevalence of problematic drug use: a review of methods and their application. Bull Narc 2002; 54: 15-32.
- 8. Larney S, Grebely J, Hickman M, et al. Defining populations and injecting parameters among people who inject drugs: implications for the assessment of hepatitis C treatment programs. Int J Drug Policy 2015; 26: 950-957.
- 9. Kimber J, Hickman M, Degenhardt L, et al. Estimating the size and dynamics of an injecting drug user population and implications for health service coverage: comparison of indirect prevalence estimation methods. Addiction 2008; 103: 1604-1613.
- 10. Kraus L, Augustin R, Frischer M, et al. Estimating prevalence of problem drug use at national level in countries of the European Union and Norway. Addiction 2003; 98: 471-485.
- 11. McKetin R, McLaren J, Kelly E, et al. Estimating the number of regular and dependent methamphetamine users in Australia (NDARC Technical Report No. 230). Sydney: National Drug and Alcohol Research Centre, 2005. https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/TR.230_0.pdf (accessed Dec 2015).
- 12. Australian Institute of Health and Welfare. Alcohol and other drugs (AODTS-NMDS) data cubes [website]. http://www.aihw.gov.au/alcohol-and-other-drug-treatment-services-data-cubes/ (accessed Dec 2015).
- 13. Topp L, Mattick RP. Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction 1997; 92: 839-845.
- 14. Harris RJ, Bradburn MJ, Deeks JJ, et al. metan: Fixed- and random-effects meta-analysis. Stata J 2008; 8: 3-28.
- 15. Kleiman M. Against excess: drug policy for results. New York, NY: BasicBooks, 1992.
- 16. Sindicich N, Burns L. Australian trends in ecstasy and related drug markets 2013: findings from the Ecstasy and related Drugs Reporting System (EDRS). (Australian Drug Trends Series No. 118). Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2014. https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/National_EDRS_2013.pdf (accessed Dec 2015).
- 17. Chalmers JJ, Lancaster K, Hughes CE. The stigmatisation of “ice” and underreporting of methamphetamine use in general population surveys: a case study from Australia [unpublished presentation]. 2015 Drug Policy Modelling Program (DPMP) Symposium; Sydney (Australia), 15 Oct 2015.
- 18. Brensilver M, Heinzerling KG, Shoptaw S. Pharmacotherapy of amphetamine-type stimulant dependence: an update. Drug Alcohol Rev 2013; 32: 449-460.
- 19. Colfax G, Santos G-M, Chu P, et al. Amphetamine-group substances and HIV. Lancet 2010; 376: 458-474.
- 20. Carroll KM. Lost in translation? Moving contingency management and cognitive behavioral therapy into clinical practice. Ann N Y Acad Sci 2014; 1327: 94-111.
- 21. McKetin R, Najman JM, Baker AL, et al. Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES). Addiction 2012; 107: 1998-2008.
- 22. McKetin R, Kelly E, McLaren J. The relationship between crystalline methamphetamine use and methamphetamine dependence. Drug Alcohol Depend 2006; 85: 198-204.
- 23. McKetin R, Ross J, Kelly E, et al. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. Drug Alcohol Rev 2008; 27: 277-285.
- 24. Stafford J, Burns L. Australia drug trends 2014. Findings from the Illicit Drug Reporting System (IDRS). (Australian Drug Trends Series No. 127). Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2015. https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/National_IDRS_2014.pdf (accessed Dec 2015).
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.